INTRODUCTION
The structurally and functionally conserved target of rapamycin complex 1 (TORC1) is a central element of a signaling pathway that integrates various hormonal, growth factor, energy, and nutritional cues to coordinate growth, metabolism, and aging (1, 2) . In yeast, activated TORC1 propagates nutrient signals mainly through the AGC protein kinase Sch9 and Tap42, a regulator of type 2A (and type 2A-like) protein phosphatases, to favor anabolic processes and inhibit catabolic processes and stress response programs (3, 4) . A primordial TORC1 input signal that cannot be compensated for by any other stimulus is provided by amino acids, in particular branched-chain amino acids such as leucine. The mechanism through which TORC1 senses amino acids requires the highly conserved Rag family of guanosine triphosphatases (GTPases), which function in heterodimeric complexes that combine RagA or RagB with RagC or RagD in higher eukaryotes, or Gtr1 with Gtr2 in yeast (5) (6) (7) . The Rag or Gtr heterodimers are asymmetrically loaded with GTP (guanosine 5′-triphosphate) and GDP (guanosine diphosphate) and can stimulate TORC1 in response to amino acids when RagA, RagB, or Gtr1 is bound to GTP. The mechanistic details of how amino acids modulate the configuration of the Rag or Gtr heterodimers are still a matter of debate, but likely involve both specific guanine nucleotide exchange factors (GEFs) and GTPase-activating proteins (GAPs). It has been proposed that lysosomal amino acids, through an inside-out mechanism that requires the vacuolar H + -ATPase (H + -translocating adenosine triphosphatase) (v-ATPase) (8) , stimulate the GEF activity of the Ragulator complex toward RagA or RagB (9, 10) . Whether this represents an ancestral mode of the regulation of Rag GTPase activity remains to be determined because yeast cells do not express apparent orthologs of critical components of the Ragulator complex and may promote GTP loading of Gtr1 through the GEF Vam6 (6, 11) . Amino acid signaling may also involve leucyl-tRNA (transfer RNA) synthetase, which acts as a leucine sensor that promotes the active conformation of the Rag heterodimers (12, 13) . A putative GAP that suppresses the activity of RagA, RagB, or Gtr1 after amino acid deprivation has yet to be identified. Here, we report on our discovery that in yeast, Iml1 functions in an Npr2/3-containing complex as a GAP for Gtr1 to decrease the activity of TORC1 and consequently growth after amino acid deprivation.
RESULTS
A genome-wide screen for regulators that inhibit TORC1 in response to amino acid deprivation identified the yeast proteins Npr2 and Npr3 (14) , which together with Iml1 assemble into a complex that is embedded within the larger, vacuolar membrane-associated SEA complex (SEAC) (15) . The Iml1-Npr2-Npr3 complex has also been proposed to promote autophagy, although independently of TORC1 (16) . To clarify the role of SEAC in TORC1 regulation, we assessed TORC1 activity in cells lacking individual components of the SEAC, all of which grew normally at 30°C and responded properly to leucine starvation in terms of phosphorylation of the eukaryotic translation initiation factor 2a (eIF2a), a sensitive indicator of the presence of uncharged tRNAs that stimulate the eIF2a kinase Gcn2 (17) (fig. S1, A and B) . Loss of Iml1, Npr2, or Npr3, but not of Sea2, Sea3, or Sea4, resulted in increased TORC1 activity, as assessed by phosphorylation of Sch9 (Fig. 1, A and B) . Together with the observation that the concomitant loss either of Npr2 and Npr3 or of Npr2, Npr3, and Iml1 stimulated TORC1 activity to similar extents (Fig. 1C  and fig. S2 ), these data indicate that Npr2, Npr3, and Iml1 share a common biological function in inhibiting TORC1. In contrast, Sea2, Sea3, and Sea4 appeared to redundantly attenuate the TORC1 inhibitory properties of the Iml1-Npr2-Npr3 complex because combined loss of Sea2, Sea3, and Sea4 (Sea2/3/4) decreased TORC1 activity in an Iml1-, Npr2-, or Npr3-dependent manner (Fig. 1C and fig. S2 ). To further dissect the roles of the individual components of the Iml1-Npr2-Npr3 complex, we overproduced Iml1, Npr2, Npr3, or Npr2 together with Npr3 and examined the corresponding effects on TORC1 activity in wild-type, iml1D, npr2D, and npr3D strains. Overproduction of Iml1 bypassed the requirement for Npr2 or Npr3 to decrease the activity of TORC1, but not vice versa (Fig. 1D) . Consistent with these genetic data, Iml1 did not require Npr2/3 or Sea2/3/4 to be recruited to the vacuolar membrane (Fig. 1, E and F) , whereas Npr2 and Npr3 depended on each other and on Iml1 for their localization to the vacuolar membrane. This led us to speculate that the functional roles within the Iml1-Npr2-Npr3 complex may be partitioned into a catalytic role for Iml1 and structural and/or regulatory roles for Npr2 or Npr3.
Our cell biological analyses revealed that Iml1 required the presence of the EGO complex [constituting Gtr1 and Gtr2 and their vacuolar membrane anchors Ego1 and Ego3 (18) ] to be efficiently localized at the vacuolar membrane (Fig. 1F) . This suggested that Iml1 may regulate TORC1 through the Gtr1-Gtr2 heterodimer. Consistent with this idea, the absence of Gtr1 or Gtr2 (or of the TORC1 subunit Tco89; Fig. 2A ) or the expression of signaling-compromised
Gtr1
S20L (which has low affinity for nucleotides) or GTP-locked Gtr2 Q66L (Fig.  2B) prevented the increase in activation of TORC1 in iml1D cells. Increased TORC1 activation in npr2D and npr3D cells was also dependent on Gtr1 (Fig. 2A) . Moreover, expression of the GTP-locked, signalingcompetent Gtr1 Q65L allele and loss of Iml1, both individually and in combination, stimulated TORC1 to a similar extent, indicating that Iml1 may in fact specifically function upstream of and inhibit Gtr1 (Fig. 2B) . Two additional observations support this notion: (i) TORC1 activity remained sensitive to loss or overproduction of Iml1 in the presence of Gtr2 S23L , which has low affinity for nucleotides (Fig. 2 , B and C), but (ii) was largely refractory to Iml1 overproduction in Gtr1 Q65L -or Gtr1
S20L
-expressing cells (Fig. 2C) . Last, as predicted by a model in which the Iml1-Npr2-Npr3 complex decreases the activity of Gtr1 after amino acid deprivation, loss of Iml1, or of Npr2 and Npr3 (individually or in combination), like overexpression of Gtr1
Q65L
, rendered TORC1 activity partially resistant to leucine starvation ( Fig. 2D  and fig. S3 ).
Our genetic epistasis analyses led us to examine whether Iml1 interacted with Gtr1 in cells. Iml1 specifically bound Gtr1 in the presence, but substantially less in the absence, of Npr2 and Npr3 ( Fig. 3A and fig.  S4 ). Moreover, although GFP-fused variants of Iml1, Npr2, and Npr3, like EGOC and TORC1 (6) , all localized to the vacuolar membrane both before and after leucine deprivation ( Fig. 3B ), bimolecular fluorescence complementation (BiFC) analysis revealed that leucine deprivation stimulated the Iml1-Gtr1 interaction specifically at the vacuolar membrane (Fig. 3C ). This was also readily observable in coimmunoprecipitation experiments in which leucine deprivation transiently stimulated the Iml1-Gtr1 interaction, but not the constitutively strong Iml1-Gtr1 Q65L interaction (Fig. 3D ). To explore whether Iml1 regulated the GTP-loading status of Gtr1 in cells, we made use of the fact that the TORC1 subunit Kog1 binds preferentially the GTP-bound form of Gtr1 (6); hence, the amount of Gtr1-associated Kog1 can be used as a proxy for the relative amount of Gtr1 GTP within cells. We observed that Iml1 overproduction reduced the Kog1-Gtr1 interaction, but not the Kog1-Gtr1 Q65L interaction (Fig. 3E ), which implicates Iml1 as a potential GAP for Gtr1. In accordance with this notion, the binding of purified Iml1 to Gtr1 was enhanced by the presence of the nonhydrolyzable GTP analog GTPgS or of GDPAlF x , which is a structural mimic of the transition state in the hydrolysis reaction by GTPases (Fig. 3F ) (19) and identifies interactions of GTPases with their cognate GAPs (20) . . Data are means ± SD from three independent experiments. (E and F) WT or mutant strains expressing the indicated functional green fluorescent protein (GFP) fusion proteins from their own promoter were analyzed by fluorescence microscopy during exponential growth. (F) egocD and seacD denote the gtr1/2D, ego1D, ego3D, and sea2-4D mutants, respectively. WT and egocD* (expressing the nuclear marker Hhf2-RFP) cells were mixed to directly compare Iml1-GFP 3 signals at the vacuolar membrane. Representative images from three independent experiments are shown. **P < 0.01; *P < 0.05; n.s., not significant, compared to the respective WT control using Student's t test (P values are Holm-Bonferroni-adjusted).
To verify our assumption that Iml1 has GAP activity toward Gtr1, we performed in vitro GAP assays with purified Iml1 and Gtr1 proteins. In a concentration-dependent manner, Iml1 stimulated the rate of GTP hydrolysis by Gtr1 to a greater extent than that by Gtr2 or the unrelated Rho GTPase Cdc42 (Fig. 4, A and B) . Analyses of truncated Iml1 versions further allowed us to specify a conserved domain in Iml1 that was required for proper TORC1 inhibition (Fig. 4C) and was sufficient to stimulate the GTP hydrolysis rate by Gtr1 in vitro (Fig. 4D) . In single-turnover GAP assays, this domain, like full-length Iml1, substantially accelerated the catalytic rate of Gtr1-mediated GTP hydrolysis and was therefore coined the Iml1 GAP domain (Iml1 GAP ; Fig. 4 , C and E). GAPs often supply a catalytic amino acid residue such as an arginine (Arg), glutamine (Gln), or aspartate (Asp) into the active site of their GTPases (19) , which prompted us to carry out an alanine scanning approach. We identified Arg 943 , which is located within Iml1 GAP (Fig. 4C) , as critical for the GAP activity of Iml1 in vitro (Fig. 4, D and E) . The R943A mutation partially, but significantly, reduced the TORC1 inhibitory function of Iml1 in cells (figs. S3 and S5, A and B). Together with the observation that GDP-AlF x promoted the in vitro interaction of Gtr1 with wild-type Iml1 and Iml1
R943A to the same extent ( fig. S6 ), these data suggest that Arg 943 is a catalytically, rather than structurally, important residue within the Gtr1 GAP Iml1. However, detailed structural analyses will be required to assess whether Arg 943 in Iml1 interacts with the catalytic domain of Gtr1. Although Gtr1-Gtr2 Q66L or Gtr1-Gtr2 S23L heterodimer formation per se stimulated the intrinsic GTPase activity of Gtr1 16-or 128-fold, respectively, Iml1 exhibited GAP activity toward both monomeric and heterodimeric Gtr1 in a comparable range (Fig.  4F) . Thus, Gtr1-mediated GTP hydrolysis in Gtr GTPase heterodimers appears to be controlled synergistically by both the GDP/GTP loading status of Gtr2 and the activity of Iml1. Finally, supporting the evolutionary conservation of our findings, we found that the human Iml1 ortholog DEPDC5 could partially rescue the TORC1 inhibition defect in iml1D cells (Fig. 4G) .
DISCUSSION
In association with Npr2 and Npr3, Iml1 functions as a GAP for Gtr1 to restrain it from activating TORC1 specifically in response to amino acid deprivation. Iml1, Npr2, and Npr3 have orthologs in humans (DEPDC5, NPRL2, and NPRL3, respectively), of which NPRL2 has previously been classified as a suppressor of various tumors (21) (22) (23) . In addition, the identification of overlapping homozygous deletions encompassing DEPDC5 (and two other genes) in two cases of glioblastoma suggests that loss of DEPDC5 may contribute to the development of cancer (24) . Because DEPDC5 could partially complement the loss of Iml1 in yeast, we speculate that the Iml1-Npr2-Npr3 complex may play an evolutionarily conserved role in suppressing Rag-mediated activation of TORC1, thereby contributing to the suppression of human tumor formation.
MATERIALS AND METHODS

Strains, growth conditions, and plasmids
Unless stated otherwise, prototrophic strains were pregrown overnight in synthetic dropout medium (0.17% yeast nitrogen base, 0.5% ammonium sulfate, 0.2% dropout mix, and 2% glucose). Before each experiment, cells were diluted to an OD 600 (optical density at 600 nm) of 0.2 and further grown at 30°C until they reached an OD 600 of 0.8. For leucine deprivation experiments, strains that were specifically auxotrophic for leucine were grown to an OD 600 of 0.8 in synthetic dropout medium with leucine (0.37 mg/ml), filtered, washed twice, and resuspended in same medium devoid of leucine. For galactose induction, precultures were grown TORC1 activity partially insensitive to leucine starvation (assayed as in Fig. 1A ).
Numbers are means ± SD from three independent experiments; one representative immmunoblot is shown. ***P < 0.001; **P < 0.01; *P < 0.05; n.s., not significant, compared to the indicated control in (A) and (C) or to WT in (B) using Student's t test (P values are Holm-Bonferroni-adjusted).
in synthetic medium (SRaf; 0.17% yeast nitrogen base, 0.5% ammonium sulfate, 0.2% dropout mix, 2% raffinose, and 0.1% sucrose). Cells were then diluted to an OD 600 of 0.2 and further grown in SRaf supplemented with 2% galactose until they reached an OD 600 of 0.8. Expression of genes under the control of the Tet ON promoter was induced by adding doxycycline (5 μg/ml) to specified medium. The S. cerevisiae strains and plasmids used in this study are listed in tables S1 and S2, respectively.
TORC1 activity assays
TORC1 activity was quantified by assessing the phosphorylation of the C-terminal part of hemagglutinin (HA)-tagged Sch9
T570
, which contains at least five bona fide TORC1 phosphorylation sites, as described previously (6, 25) . Briefly, after chemical cleavage with NTCB (2-nitro-5-thiocyanatobenzoic acid), extracts were separated by 7.5% SDS-polyacrylamide gel electrophoresis (PAGE), and membranes were probed with anti-HA antibodies (12CA5) and anti-mouse immunoglobulin G (IgG) antibodies coupled to horseradish peroxidase (HRP) (Bio-Rad). Alternatively (in Fig. 1B) , TORC1 activity was estimated as the ratio between the phosphorylation on Thr 737 of fulllength Sch9-HA 5 compared to the total abundance of Sch9-HA 5 (using phosphospecific anti-pThr 737 -Sch9 and 12CA5 antibodies, respectively) as previously described (26) .
Coimmunoprecipitation
Yeast cells expressing the indicated fusion proteins were harvested by filtration. Filters were immediately snap-frozen in liquid nitrogen and stored at −80°C. Cells were resupended in lysis buffer [50 mM Hepes/KOH (pH 7.4), 150 mM NaCl, 10 mM MgCl 2 , 0.2% NP-40 (for myc-Iml1) or 0.5% NP-40 (for Kog1-HA), protease and phosphatase inhibitor cocktails (Roche)] and lysed with glass beads using the Precellys cell disruptor. Lysates were diluted in the same lysis buffer (for myc-Iml1) or a buffer devoid of NP-40 (for Kog1-HA) and clarified by two successive centrifugations for 10 min at 13,000 rpm. For input samples, aliquots of cleared lysates were concentrated by precipitation with icecold acetone, resuspended in 6× concentrated loading buffer, and denatured for 10 min at 95°C. For coimmunoprecipitations, cleared lysates were incubated for 2 hours at 4°C with prewashed IgG Sepharose beads (GE Healthcare). After three washes with wash buffer (same as lysis buffer for myc-Iml1 or containing 450 mM NaCl for Kog1-HA), beads were resuspended in 6× concentrated loading buffer and denatured for 10 min at 95°C. Inputs (25 μg) and pull-down samples (2000 μg for myc-Iml1, 500 μg for Kog1-HA, and 125 or 67.5 μg for Gtr1-TAP) were analyzed by SDS-PAGE immunoblot with anti-myc (9E10; Santa Cruz Biotechnology), anti-HA (HA.11; Covance), and anti-TAP (Open Biosystems) antibodies together with light chain-specific anti-mouse or antirabbit HRP-conjugated antibodies (Jackson ImmunoResearch).
Protein purification
Glutathione S-transferase (GST)-Gtr1, GST-Gtr2, GST-Gtr2 (S23L or Q66L), Gtr1-His 6 , GST-Cdc42, and GST-Iml1 GAP were produced in the Escherichia coli Rosetta strain after induction with 0.5 mM IPTG (isopropylb-D-thiogalactopyranoside) for 5 hours at 18°C [GST-Gtr1, GST-Gtr2, and GST-Gtr2 (S23L or Q66L) plus Gtr1-His 6 ], 30°C (GST-Iml1 GAP ), or 37°C (GST-Cdc42). Cells were collected by centrifugation and lysed with a microfluidizer. Protein fusions were purified with glutathione-Sepharose beads (GE Healthcare), which were washed with buffer A [50 mM TrisHCl (pH 7.5), 200 mM NaCl, 1.5 mM MgCl 2 , 5% glycerol, 1 mM dithiothreitol (DTT), 0.1% NP-40, and 0.1 mM GDP] for GST-Gtr1, GST-Gtr2, GST-Gtr2 (S23L or Q66L) plus Gtr1-His 6 , and GST-Cdc42, or buffer B [50 mM Tris-HCl (pH 7.5), 500 mM NaCl, 1.5 mM MgCl 2 , 5% glycerol, 1 mM DTT, 1% Triton X-100, and 0.1% Tween 20] for GSTIml1 GAP . Proteins were eluted with buffer A plus 10 mM reduced glutathione (without GDP in the case of GST-Iml1 GAP ). Glycerol was added to a final concentration of 20%. Proteins were snap-frozen in liquid nitrogen and stored at −80°C. For the purification of full-length Iml1 and Iml1
R943A
, yeast iml1D gtr1D double-mutant cells expressing Iml1-or Iml1
-His 6 -TEV-(tobacco etch virus)-cleavage-site-ProteinA were grown in synthetic dropout medium overnight, diluted to an OD 600 of 0.2 in YPD (yeast extract, peptone, and dextrose), and further grown to an OD 600 of 2.0. Cells were then collected by centrifugation and lysed with a planetary micro mill (Pulverisette). Protein fusions were purified with IgG Sepharose beads (GE Healthcare), which were washed with buffer C [20 mM Hepes (pH 7.4), 300 mM NaCl, 110 mM potassium acetate (KOAc), 2 mM MgCl 2 , 0.1% Tween 20, 1% Triton X-100, 1 mM DTT] (15). After overnight TEV cleavage, a second purification step was performed with Ni-NTA agarose beads (Qiagen), which were washed with buffer C plus 10 mM imidazole. Proteins were eluted with buffer D [20 mM Hepes (pH 7.4), 75 mM NaCl, 110 mM KOAc, 2 mM MgCl 2 , and 300 mM imidazole]. Glycerol was added to a final concentration of 20%. Proteins were snap-frozen in liquid nitrogen and stored at −80°C.
In vitro Gtr1-Iml1 binding assays
Purified GST-Gtr1 or GST alone (100 nM final) was incubated for 30 min at room temperature in loading buffer [20 mM Tris-HCl (pH 8.0), 2 mM EDTA, and 1 mM DTT] in the presence of either GTPgS (100 mM final), GTP (1 mM final), GDP (1 mM final), or GDP + AlF x (1 mM GDP, 2 mM AlCl 3 , and 20 mM NaF final concentration). Subsequently, purified Iml1-His 6 (100 nM) and MgCl 2 (10 mM) were added, and the mix was incubated for 1 hour at 4°C. Pull-down experiments were performed with glutathione-Sepharose beads (Qiagen), which were washed with loading buffer containing 10 mM MgCl 2 (or 10 mM MgCl 2 , 2 mM AlCl 3 , and 20 mM NaF; GDP plus AlF x ). Finally, beads were resuspended in 2× Laemmli buffer and boiled, and the supernatants were used for SDS-PAGE immunoblot analyses.
GTP hydrolysis assays
GAP assays were performed essentially as previously described (27, 28) . Briefly, GTPases (100 nM) were incubated for 30 min at room temperature in loading buffer [20 (1 μM) as described above, except that 1.7 mM unlabeled GTP was added simultaneously with MgCl 2 . GTP hydrolysis (±SD; n = 3 independent experiments) by the indicated combinations of Gtr GTPases (with or without Iml1-His 6 ; normalized to the one of Gtr1 without Iml1-His 6 ). (G) Human DEPDC5 partially complements the TORC1 inhibition defect in iml1D cells. TORC1 activities were assayed as in Fig. 1A . Fusion protein expression was confirmed by immunoblot analysis. ***P < 0.001; n.s., not significant, compared to the respective WT control using Student's t test (P values are Holm-Bonferroni-adjusted). Data are means ± SD from three independent experiments. Fig. S1 . Loss of individual SEAC subunits does not substantially affect the growth of cells at 30°C or eIF2a phosphorylation after leucine starvation. Fig. S2 . Effects on TORC1 activity of various combinations of individual deletions of SEAC subunit-encoding genes. Fig. S3 . Loss of Iml1-Npr2-Npr3 complex subunits, individually or in combination, or expression of Gtr1 Q65L or of Iml1 R943A renders TORC1 activity partially insensitive to leucine starvation. Table S1 . Strains used in this study. Table S2 . Plasmids used in this study. References (30) to (34) 
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